PET-MRI imaging study for arrhythmogenic heart disease
Treatments studied
Part of Heart & circulation clinical trials.
This study uses a special whole-heart scan (PET combined with MRI) to better understand the tissue and metabolism patterns in people with arrhythmogenic cardiomyopathy. The goal is to see whether these scan patterns relate to symptoms now and how the disease may change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 16 or older (male or female)
- The study is for people with arrhythmogenic cardiomyopathy who do NOT have excluded genetic-risk profiles
- You do not have sarcoidosis or a known autoimmune disease
- You have no history of heart attack (myocardial infarction)
- You can legally consent for yourself (not under court protection/guardianship)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of heart scan (FAPI PET/CT) to better visualize and understand arrhythmogenic right ventricular cardiomyopathy (ARVC), a condition where the heart muscle weakens and causes irregular heartbeats. The scan may help doctors understand the disease better and improve patient care.
This study uses a special MRI approach to measure details of your heart muscle in people with certain heart problems. It may help researchers better understand how different conditions affect the heart and how those changes can be measured.
This study uses advanced imaging (PET/MR or PET/CT) to look at scarring (fibrosis) in the heart muscle. It is for people with various heart muscle diseases, including heart failure with preserved pumping, thickened heart muscle, high blood pressure-related heart damage, heart inflammation, and others.
This study uses advanced magnetic resonance imaging (MRI) scans to better understand and diagnose heart disease. If you have suspected or confirmed heart problems, this trial may help doctors get clearer pictures of your heart muscle and tissue to figure out what's causing your symptoms.
This study uses heart MRI to find people with early signs of heart muscle disease who still have normal-sized heart chambers. It aims to better predict who is at risk so they can get earlier care.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
Hear when a new Arrhythmogenic Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.